The required information typically includes: Diagnosis: Documentation of the patients condition, such as type 2 diabetes, obesity, hypertension, or cardiovascular issues, that warrants the use of a GLP-1 medication
B, Schuemie M, DeFalco F, Yuan Z, Stang P et al
For more information, the above stated ICE model can be found here
Artificial intelligence to deep learning: machine intelligence approach for drug discovery
Solucin Reafirmante Fco x 100 ml | TR7 $154,600 IVA incl
For this reason, it is not FDA-approved and has raised concerns over its safety, with the FDA warning in 2024 it had received reports of hospitalizations and adverse effects from use of compounded semaglutide injections due to dosing errors